“…Given two recent studies by Shahbazi et al (2002) and Stove et al (2003) on the importance of EGF and heregulin/HER receptor signaling in melanoma development, we would like to contribute our data of EGF receptor signaling in normal human melanocytes (NHM), which has become an area of recent controversy. In contrast to the recent report by Grahn and Isseroff (2004) in the Journal , our data clearly show that NHM express the EGF receptor and that tyrosine kinase‐mediated signaling occurs in response to recombinant EGF. In addition, the majority of previous reports argues for the EGF receptor being expressed on in situ melanoma and cultured melanoma cells as analyzed by several different techniques (Real et al , 1986; de Wit et al , 1992; Ellis et al , 1992; Mattei et al , 1994; Huang et al , 1996; Ivanov and Hei, 2005), whereas other investigators have not found this to be true (Halaban, 2000; Grahn and Isseroff, 2004).…”